DSM, a global science-based company active in health, nutrition and materials, and AdeTherapeutics, a clinical-stage product development company located in Canada, signed a joint collaboration agreement to accelerate DSM's scar reduction and pain management product development strategy in neurosurgery, according to a news release.
The build-up of scar tissue has been linked to 20-36 percent of failed back surgery syndrome which can cause chronic pain and difficulty operating on the spine again.
Related Articles on Pain Management:
Neuros Medical Receives Approval for Pilot Study of Electrical Nerve Block Technology
American Medical Association to Help Physicians Prevent Misuse and Abuse of Prescription Opioids
Global Pain Management Therapeutics Market Sales Forecasted to Reach $35.1B by 2017
The build-up of scar tissue has been linked to 20-36 percent of failed back surgery syndrome which can cause chronic pain and difficulty operating on the spine again.
Related Articles on Pain Management:
Neuros Medical Receives Approval for Pilot Study of Electrical Nerve Block Technology
American Medical Association to Help Physicians Prevent Misuse and Abuse of Prescription Opioids
Global Pain Management Therapeutics Market Sales Forecasted to Reach $35.1B by 2017